典型文献
Study on Immunotherapy-related Biomarkers of Small-cell Lung Cancer
文献摘要：
The prognosis of small cell lung cancer is poor. Almost all patients have a tendency for tumor spreading to the whole body when they are diagnosed. Therefore, the combination of radiotherapy and chemotherapy is the main treatment, and surgical treatment is only implemented in a small number of limited patients. In recent years, there has been no obvious breakthrough in the treatment of small cell lung cancer, and the overall poor prognosis has not changed. With the development of medical technology, immune checkpoint inhibitors are gradually applied to the treatment of small-cell lung cancer, but the overall effect is limited. How to screen the beneficiary population to fur-ther improve the effect of immunotherapy is the key issue in the treatment of small-cell lung cancer.
文献关键词：
中图分类号：
作者姓名：
LI Yu-yan;LI Shan-shan;FAN Li;ZHANG Bin
作者机构：
Jilin Kingmed for Clinical Laboratory Co.,Ltd.,Changchun Jilin 130000,China
文献出处：
引用格式：
[1]LI Yu-yan;LI Shan-shan;FAN Li;ZHANG Bin-.Study on Immunotherapy-related Biomarkers of Small-cell Lung Cancer)[J].中国生物医学工程学报（英文版）,2022(01):27-32
A类：
B类：
Study,Immunotherapy,related,Biomarkers,Small,cell,Lung,Cancer,prognosis,small,lung,cancer,poor,Almost,patients,have,tendency,tumor,spreading,whole,body,when,they,are,diagnosed,Therefore,combination,radiotherapy,chemotherapy,main,treatment,surgical,only,implemented,number,limited,In,recent,years,there,has,been,obvious,breakthrough,overall,changed,With,development,medical,technology,immune,checkpoint,inhibitors,gradually,applied,but,effect,How,screen,beneficiary,population,fur,improve,immunotherapy,key,issue
AB值：
0.60139
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
